Akèy › Maladi kadyovaskilè › Tennessee › Nashville
Etid klinik pou Maladi kadyovaskilè nan Nashville, TN
18 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Ap rekriteFaz 4
- TriStar Centennial Medical Center, Nashville
ELEVATE-HFpEF Clinical Study
Ap rekrite
- Saint Thomas Research Institute, Nashville
Improving Veteran Referral to Cardiac Rehabilitation
Ap rekrite
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Product Surveillance Registry
Ap rekriteEtid obsèvasyon
- Nashville, Nashville
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Ap rekrite
- Vanderbilt University Medical Center, Nashville
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Ap rekriteFaz 3
- Vanderbilt Univ Medi Cen, Nashville
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Ap rekrite
- Vanderbilt University Medical Center, Nashville
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Ap rekriteFaz 4Volontè an sante akeyi
- Meharry Medical College, Nashville
- Nashville VA Medical Center, Nashville
- Vanderbilt University Medical Center, Nashville
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Ap rekriteFaz 2
- Vanderbilt University Medical Center, Nashville
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Ap rekriteFaz 3
- Research Site, Nashville
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Ap rekriteFaz 3
- Ascension Saint Thomas, Nashville
Global Paradise System US Post Approval Study
Ap rekriteEtid obsèvasyon
- Ascension Saint Thomas, Nashville
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Ap rekrite
- Vanderbilt, Nashville
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Ap rekriteFaz 2
- Vanderbilt University Medical Center, Nashville
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Ap rekrite
- Centennial Medical Center, Nashville
Randomized Trial of SGLT2i in Heart Transplant Recipients
Ap rekriteFaz 4
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Gut Microbiota in Metabolic Surgery
Ap rekriteEtid obsèvasyon
- Vanderbilt_University MC, Nashville
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Ap rekrite
- Centennial Medical Center, Nashville
Etid Maladi kadyovaskilè nan lòt vil
- Boston, MA37 etid
- New York City, NY33 etid
- Washington, DC28 etid
- Houston, TX24 etid
- Dallas, TX23 etid
- Atlanta, GA22 etid
- Cleveland, OH22 etid
- Chicago, IL21 etid
- Philadelphia, PA21 etid
- Pittsburgh, PA20 etid
- St. Louis, MO20 etid
- San Francisco, CA18 etid
Lòt etid nan Nashville
- Kansè Poumon ki pa ti selil97 etid
- Kansè nan tete81 etid
- Kansè Metastatik70 etid
- Kansè kolorektal69 etid
- Kansè (tout kalite)65 etid
- Kansè ovè49 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Karsinòm selil skuamèz tèt ak kou39 etid
- Kansè pankreyas39 etid
- Kansè Endomèt38 etid
- Melanom33 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.